Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
Status:
Active, not recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, longitudinal, multicenter study conducted in a cohort of patients with
early CD. This study will not change the patient/physician relationship.
Phase:
Phase 4
Details
Lead Sponsor:
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives